ClinicalTrials.gg
Status unknownNCT01225770Updated Feb 15, 2013

Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers

A Phase 3 interventional study of green tea in Influenza Infection, sponsored by University of Shizuoka. Status unknown at 1 site in Japan. Open to participants aged 15 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-02-15.

Sponsored by University of Shizuoka · Phase 3, Interventional, and Prevention

How we know

The sponsor has not verified this record recently (last verified Feb 2013), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
640
Allocation
Randomized
Ages
15 Years to 20 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Influenza, Human with a site in Japan — 4 open to participants now, 4 under way, 3 of them phase 3. Influenza, Human · Japan.

Planned enrollment
12th of 40
640 · median 169
Started
2010
with 4 others
Phase 3
16 of 42
3 open now
Registered
18th of 42
by date
Lead sponsor
3 of 42
University of Shizuoka

Among the 42 studies in Influenza, Human with a site in Japan, this one is the 12th largest by planned enrollment of the 40 interventional ones that give a count, is one of 5 that started in 2010, is one of 16 in phase 3, and was the 18th registered.

Influenza, Human

2,361 studies on the registry are indexed under Influenza, Human; 186 are open to participants now.

Browse Influenza, Human studies →

Open to participants now

4 of the 42 studies in Influenza, Human with a site in Japan are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →

Who these studies take

Of the 124 Influenza, Human studies recruiting now, 67 (54%) set no upper age limit and 47 (38%) stop at 75 or younger; 34 take children under 18; 69 take healthy volunteers.

This study: 15 Years to 20 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Influenza, Human with a site in Japan, or all of them as a file.
02

Study summary

Experimental and clinical studies in adults have reported that green tea catechins prevent influenza infection. In this clinical randomized study, the investigators aimed to determine the effects of gargling with green tea on the prophylaxis of influenza infection among high school teenagers.

Read the detailed description

Influenza infection is the principal cause of acute respiratory illnesses and occurs in epidemic or pandemic worldwide. It spreads easily among high school students and from them to the rest of the community; therefore the prevention of influenza is very important.

Experimental studies have revealed that some components of green tea can prevent influenza infection in vitro. In clinically, gargling with green tea catechins has been reported to have possibilities to preventing influenza infection in adults; however, little clinical evidence in teenagers has so far been existed. Based on this background, the investigators designed a randomized study to evaluate the clinical efficacy of gargling with green tea in preventing influenza infection among high school students.

03

Conditions studied

  • Influenza Infection

Keywords

  • green tea
  • gargling
  • prophylaxis
  • influenza
  • Respiratory Tract Infections
  • high school students
04

Who can participate

Ages eligible
15 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged from 15 to 20 years
  • obtained written from both the student and parent before participation
  • possible to gargle during 90 days
  • possible to fill in questionnaire

Exclusion criteria

Exclusion Criteria:

  • Possessing allergy to green tea
  • Possessing history of influenza infection within 6 months before entering the study
  • Possessing severe immune disease or whole body infection
  • severe cardiac, respiratory, renal, or hepatic dysfunction
  • diagnosed as inadequate to participate in the study by student doctor
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
640 participants (estimated)

Study arms

  • Experimental
    Green tea

    Gargling with green tea

    Dietary Supplement: green tea

  • Active comparator
    water

    Gargling with water

    Dietary Supplement: green tea

Interventions

06

What researchers measure

Primary outcomes

  1. the incidence rates of influenza infection

    Time frame: Until 3 months gargling

Secondary outcomes

  1. severity of influenza symptoms

    Time frame: until 3 months gargling

  2. influenza-free time during the study period

    Time frame: until 3 months gargling

  3. incidence of complications

    Time frame: until 3 months gargling

  4. incidence rates of upper respiratory tract infections

    Time frame: until 3 months gargling

  5. incidence of days of absence from school

    Time frame: until 3 months gargling

  6. occurrence of the adverse events

    Time frame: until 3 months gargling

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Ide K, Yamada H, Matsushita K, Ito M, Nojiri K, Toyoizumi K, Matsumoto K, Sameshima Y. Effects of green tea gargling on the prevention of influenza infection in high school students: a randomized controlled study. PLoS One. 2014 May 16;9(5):e96373. doi: 10.1371/journal.pone.0096373. eCollection 2014. PubMed 24836780 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2010, a primary completion of Apr 2014 and a completion of Aug 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 19, 2010
First posted
Oct 21, 2010
Start
Nov 2010
Primary completionEst.
Apr 2014
CompletionEst.
Aug 2014
Last update
Feb 15, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 15, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01225770
Lead sponsor
University of Shizuoka
Responsible party
Sponsor
First posted
Oct 21, 2010
Start date
Nov 2010
Primary completion
Apr 2014 (estimated)
Completion
Aug 2014 (estimated)
Last update
Feb 15, 2013

Study contacts

Hiroshi Yamada, MD, PhD
Contact
hyamada@u-shizuoka-ken.ac.jp
+81-54-264-5762
Keiji Matsumoto, MS
Contact
d10902@u-shizuoka-ken.ac.jp
+81-54-264-5770
Hiroshi Yamada, MD, PhD
study chair · University of Shizuoka

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tea

Start the discussion